PD 85639: sodium channel blocker; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 132888 |
| SCHEMBL ID | 14810141 |
| MeSH ID | M0218123 |
| Synonym |
|---|
| benzeneacetamide, 3-(2,6-dimethyl-1-piperazinyl)-alpha-phenyl-alpha-propyl- |
| alpha-phenyl-n-(3-(2,6-dimethyl-1-piperizinyl)alpha-propyl)benzeneacetamide |
| pd85,639 |
| pd 85639 |
| 2-[3-(2,6-dimethylpiperazin-1-yl)phenyl]-2-phenylpentanamide |
| SCHEMBL14810141 |
| DTXSID20933765 |
| 2-[3-(2,6-dimethylpiperazin-1-yl)phenyl]-2-phenylpentanimidic acid |
| benzeneacetamide, n-[3-(2,6-dimethyl-1-piperidinyl)propyl]-alpha-phenyl- |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||